Gilead Sciences (GILD) Gross Profit (2009 - 2026)

Gilead Sciences (GILD) has reported Gross Profit for 18 consecutive years, with $5.5 billion the latest figure, recorded in Q1 2026.

• Gross Profit for Q1 2026 came in at $5.5 billion, up 7.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.6 billion (up 4.89% YoY), and the FY2025 annual result was $23.2 billion, up 3.14% from the prior year.
• Gross Profit was $5.5 billion for Q1 2026 at Gilead Sciences, down from $6.3 billion in the prior quarter.
• Over five years, Gross Profit peaked at $6.3 billion in Q4 2025 and troughed at $4.8 billion in Q2 2022.
• Average Gross Profit over 5 years is $5.5 billion, with a median of $5.5 billion recorded in 2023.
• Year-over-year, Gross Profit rose 29.8% in 2022 and retreated 16.17% in 2023.
• Over 5 years, Gross Profit stood at $6.0 billion in 2022, then declined by 16.17% to $5.0 billion in 2023, then climbed by 19.19% to $6.0 billion in 2024, then climbed by 5.23% to $6.3 billion in 2025, then fell by 12.47% to $5.5 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $5.5 billion in Q1 2026, $6.3 billion in Q4 2025, and $6.2 billion in Q3 2025.